Multifactorial Prediction of Anthracycline-Induced Cardiotoxicity in Childhood Cancer: 10 Years of Active Surveillance and Pharmacogenomics Studies at the Canadian Pharmacogenomics...

by Aminkeng, Folefac, Rassekh, Shahrad, Bhavsar, Amit, Luo, Hao, Wright, Galen, Drogemoller, Britt, Rieder, Michael, Hayden, Michael, Ross, Colin, Carleton, Bruce
Published 2022

An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclines

by Dionne, Francois, Aminkeng, Folefac, Bhavsar, Amit P, Groeneweg, Gabriella, Smith, Anne, Visscher, Henk, Rassekh, Shahrad Rod, Ross, Colin, Carleton, Bruce
Published 2022

MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ

by Van Autreve, Jan E, Koeleman, Bobby PC, Quartier, Erik, Aminkeng, Folefac, Weets, Ilse, Gorus, Frans K, Van der Auwera, Bart JR
Published 2022

Pharmacogenomic prediction of immune-related adverse events from immune checkpoint inhibitors among Asian patients

by Huang, Yiqing, Aminkeng, Folefac, Wong, Alvin SC, Tay, Sen Hee, Zhao, Joseph J, Ang, Yvonne, Soo, Ross A, Goh, Boon Cher
Published 2022

IFIH1 gene polymorphisms in type 1 diabetes: Genetic association analysis and genotype-phenotype correlation in the Belgian population

by Aminkeng, Folefac, Van Autreve, Jan E, Weets, Ilse, Quartier, Erik, Van Schravendijk, Chris, Gorus, Frans K, Van der Auwera, Bart J
Published 2022

TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ

by Aminkeng, Folefac, Van Autreve, Jan E, Koeleman, Bobby PC, Quartier, Erik, Van Schravendijk, Chris, Gorus, Frans K, Van der Auwera, Bart JR
Published 2022

Pharmacogenomic Prediction of Cisplatin-Induced Nephrotoxicity in Patients Treated for Childhood Cancer

by Medeiros, Mara, Aminkeng, Folefac, Jimenez-Triana, Climaco, Rivas-Ruiz, Rodolfo, Juarez, Luis, Palomo, Martin, Clark, Patricia, Castaneda-Hernandez, Gilberto, Ross, Colin, Carleton, Bruce
Published 2022

Association of IL-2RA/CD25 with type 1 diabetes in the Belgian population

by Aminkeng, Folefac, Weets, Ilse, Van Autreve, Jan E, Koeleman, Bobby PC, Quartier, Erik, Van Schravendijk, Chris, Gorus, Frans K, Van der Auwera, Bart JR
Published 2022

Risk factors for immune-related adverse events from anti-PD-1 or anti-PD-L1 treatment in an Asian cohort of nonsmall cell lung cancer patients

by Huang, Yiqing, Soon, Yu Yang, Aminkeng, Folefac, Tay, Sen Hee, Ang, Yvonne, Kee, Adrian CL, Goh, Boon Cher, Wong, Alvin SC, Soo, Ross A
Published 2022

Predicting Anthracycline-induced Cardiotoxicity in Children - Genome-Wide Association Study

by Aminkeng, Folefac, Ross, Colin JD, Rassekh, Rod S, Brunham, Liam R, Weissman, Cory, Dube, Marie-Pierre, Visscher, Henk, Rieder, Michael J, Carleton, Bruce C, Hayden, Michael R
Published 2022

Pharmacogenomic screening for anthracycline-induced cardiotoxicity in childhood cancer

by Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Rieder, Michael J, Bhavsar, Amit P, Sanatani, Shubhayan, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Published 2022

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients

by Chan, Sze Ling, Chua, Angeline Poh Gek, Aminkeng, Folefac, Chee, Cynthia Bin Eng, Jin, Shengnan, Loh, Marie, Gan, Suay Hong, Wang, Yee Tang, Brunham, Liam R
Published 2022

Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung Cancer

by Huang, Yiqing, Zhao, Joseph J, Soon, Yu Yang, Kee, Adrian, Tay, Sen Hee, Aminkeng, Folefac, Ang, Yvonne, Wong, Alvin SC, Bharwani, Lavina D, Goh, Boon Cher, Soo, Ross A
Published 2023

Pharmacogenomic Prediction of Ribavirin-Induced Hemolytic Anemia in Patients Treated for Hepatitis C Infection

by Abel, Shawna, Aminkeng, Folefac, Kowalec, Kaarina, Drogemoller, Britt, Wright, Galen, Bader, Rachel, Stortz, Jessica, Yoshida, Eric, Lee, Sam, Al-Judaibi, Bandar, Kim, Richard, Tam, Edward, Ramji, Alnoor, Ross, Colin, Carleton, Bruce
Published 2022

Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the Literature

by Tay, Sen Hee, Toh, Michelle Min Xuan, Thian, Yee Liang, Vellayappan, Balamurugan A, Fairhurst, Anna-Marie, Chan, Yiong Huak, Aminkeng, Folefac, Bharwani, Lavina D, Huang, Yiqing, Mak, Anselm, Wong, Alvin Seng Cheong
Published 2022

Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity

by Aminkeng, Folefac, Ross, Colin JD, Rassekh, Shahrad R, Hwang, Soomi, Rieder, Michael J, Bhavsar, Amit P, Smith, Anne, Sanatani, Shubhayan, Gelmon, Karen A, Bernstein, Daniel, Hayden, Michael R, Amstutz, Ursula, Carleton, Bruce C
Published 2022

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer

by Huang, Yiqing, Zhao, Joseph J, Soon, Yu Yang, Wong, Alvin, Aminkeng, Folefac, Ang, Yvonne, Asokumaran, Yugarajah, Low, Jia Li, Lee, Matilda, Choo, Joan RE, Chan, Gloria, Kee, Adrian, Tay, Sen Hee, Goh, Boon Cher, Soo, Ross A
Published 2022

Unbiased profiling of isogenic huntington disease hPSC-derived CNS and peripheral cells reveals strong cell-type specificity of CAG length effects

by Ziaei, Amin, Zeng, Ruizhu, Low, Donovan, Aminkeng, Folefac, Sobota, Radoslaw M., Ginhoux, Florent, Petretto, Enrico, Pouladi, Mahmoud A., Langley, Sarah Raye, Ooi, Jolene, Xu, Xiaohong, Utami, Kagistia H., Sim, Bernice, Huang, Yihui, Harmston, Nathan P., Tay, Yi Lin
Published 2019

Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patients

by Asanghanwa, Milca, Gorus, Frans K, Weets, Ilse, Auwera, Bart V der, Aminkeng, Folefac, Mbunwe, Eric, Goubert, Patrick, Verhaeghen, Katrijn, Sobngwi, Eugene, Wenzlau, Janet M, Hutton, John C, Pipeleers, Daniel G, Keymeulen, Bart, Mbanya, Jean-Claude N, van Schravendijk, Chris
Published 2022

Genetic Variation in SLC16A5 Confers Protection from Cisplatin-Induced Ototoxicity in Adult Testicular Cancer Patients

by Drogemoller, Britt, Monzon, Jose, Bhavsar, Amit, Borrie, Adrienne, Brooks, Beth, Wright, Galen, Liu, Geoffrey, Fadhel, Ehab, Renouf, Daniel, Kollmannsberger, Christian, Bedard, Philippe, Aminkeng, Folefac, Hildebrand, Claudette, Gunaretnam, Erandika, Critchley, Carol, Chen, Zhou, Brunham, Liam, Hayden, Michael, Ross, Colin, Gelmon, Karen, Carleton, Bruce
Published 2022